
    
      PRIMARY OBJECTIVES:

      I. To determine the symptom improvement after 2 weeks of therapy with bandage lenses.

      SECONDARY OBJECTIVES:

      I. To confirm short-term safety within 1 month after bandage lenses.

      II. To determine improvement in ophthalmologic examinations after bandage lenses.

      III. To explore the use of optical coherence tomography as an objective measure of corneal
      inflammation.

      OUTLINE:

      Patients wear bandage lenses continuously for at least 3 months in the absence of disease
      progression or unacceptable toxicity.
    
  